Thomas
S. Dma,
Primary versus
MD
Central Toxoplasmosis
The imaging studies of 16 patients with acquired immunodeficiency syndrome (AIDS) and proved primary central nervous system (CNS) lymphoma were reviewed. All studies included computed tomography (CT); six also included magnetic resonance (MR) imaging. A periventricular lesion was seen in 50% of patients. At least one such lesion cxhibited subependymal spread or ventricular encasement in 38%. One-third of lesions in three of five patients who underwent nonenhanced CT were hyperattenuating. Five lesions were at least in part hypointense on T2-weighted MR images. The specificity of these findings was evaluated with a similar review of the imaging studies in 28 patients with AIDS and proved toxoplasmosis. Only 3% of lesions were periventricular. None exhibited subependyntal spread or encasement. None were hyperattenuating on nonenhanced CT scans. Similar findings in other CNS lesions in AIDS patients could not be found in the literature. A focal enhandng mass with subependymal spread on CT or MR Images and hyperattenuation at nonenhanced CT were the most reliable features in distinguishing between primary CNS lyinphoma and toxoplasmosis in AIDS patients. Index terms: Acquired immunodeficiency syndrome (AIDS) #{149} Brain neoplasms, CT,
10.1211, 10.34 #{149} Brain neoplasms, MR studies, 10.1214, 10.34 #{149} Lymphoma, CT, 10.1211, 10.34. Lymphoma, MR studies, 10.1214, 10.34 #{149} Toxoplasmosis, 10.2074 Radiology
1991; 179:823-828
Nervous
T
System in AIDS’
Lyinphoina
of central nervous system (CNS) lymphoma in patients with the acquired immunodeficiency syndrome (AIDS) has inHE incidence
creased.
Malignant
lymphoma
is sec-
ond in frequency only to toxoplasmoMs among CNS mass lesions in AIDS patients (1). However, reports of the computed tomographic (CT) appearance of primary CNS lymphoma in AIDS patients vary; some authors describe focal lymphoma mass lesions as being similar to those in patients without AIDS, while others describe differences (2,3). Also, while the CT appearance is generally described as an enhanced mass or multiple masses exhibiting diffuse or
ring tion
enhancement
with
a predilec-
for the corpus callosum, basal ganglia, and periventricular areas, the reported frequency of such findings varies (4-14). This variance is at least in part due to the relatively small number of cases of lymphoma, even in reviews of large numbers of CNS lesions in patients with AIDS. The spectrum of CT appearances often includes normal CT scans as well as nonspecific
findings
of atrophy
and white matter area of low aftenuation in a number of proved cases, leaving a smaller number of focal lesions from which to tabulate findings. On CT scans, toxoplasmosis may also appear as solitary or multiple, ring- or nodular-enhancing masses (3,9,15-17). Delayed double-dose contrast material-enhanced CT increases the detection rate and conspicuity of lesions, and magnetic resonance (MR) imaging further increases sensitivity in lesion detection (1 1,13,18). Imaging studies, however, remain nonspecific. It is therefore
3 From the Department of Radiology, George Washington University Medical Center, 901 23rd St, NW, Washington, DC 20037. Received October 9, 1990; revision requested November 26; revision received February 13, 1991; accepted February 25. Address reprint requests to the author. 0 RSNA, 1991
generally accepted that primary CNS lymphoma is indistinguishable from toxoplasmosis (5,12,19). We have encountered several cases of focal lymphoma mass lesions that were subependymal in location and surrounded and constricted (encased) a portion of the ventricle. A subependymal location of enhancing focal lymphoma mass lesions has been described in both nonimmunocompromised and AIDS patients, but without documentation of the relative prevalence
of this
finding
or differ-
entiation lesions
from other periventricular (8,11). The finding of ventricular encasement has been illustrated without comment as to the frequency or potential significance of the finding (1 1,13,20). Ventricular encasement has been described on CT scans in two of 32 patients by Goldstein et al(14). The purpose of our study was to review our experience with the neuroimaging of primary CNS non-Hodgkin lymphoma and toxoplasmosis in the AIDS population and to review reported cases to further define their imaging characteristics. To be specific, we wished to determine the preyalence of subependymal spread and ventricular encasement in lymphoma and the prevalence, if any, of this appearance in toxoplasmosis. PATIENTS
AND
METHODS
The neuroimaging studies and medical records of patients with a confirmed diagnosis of AIDS were reviewed. Of 59 patients with diagnoses of AIDS and lymphoma, 41 had systemic non-Hodgkin lymphoma with or without CNS involvement. Thirty-one of these patients had extranodal
lymphoma
(including
four
with
CNS involvement); in 10, the full extent of disease was not defined. There was one
Abbreviations: ficiency
syndrome,
AIDS CNS
-
acquired central
immunodenervous sys-
tem.
823
case
of Hodgkin
maining
lymphoma.
17 patients
sions,
systemic
who
In the
re-
brain
le-
had
non-CNS
lymphoma
Table
1
Lesion
was
Number,
Presentation,
excluded on clinical grounds. The history and physical examination were supported by
negative
men,
CT
and/or
studies
of the
pelvis
appropriate
and
negative
lymph
node
biopsies,
and
considered
chest,
bone
Lesion presentation Solitary
with
Lesions
Although
primary
CNS
was excluded in which specimen was suggesbut insufficient for deThe lymphoma study
group
included
therefore
imaging
studies
and
or autopsy-proved lymphoma. There
woman years).
16 patients biopsy(n 15)
(n were
aged 23-46 The 15 men
12) or bisexual likely acquired transfusion.
years were
with and/
(mean, 36.6 homosexual
lesions
each
were
of the
plasmosis sponse
identical,
=
to a clinical
anti-Toxoplasma tients (in one
complete,
of the
sone, resulting but no radiographic
in
tients tested Toxoplasma
=
(n
studies fluid for preparations
bacteria
titers,
The
of 40 patients for the proved
nosis
of toxoplasmosis
To be included also
imaging clinical nosis
fined lesion cific
=
studies
presentation; was based
on
imaging response.
patients, sone in
with the five. Since
gree or intensity be due to steroid
to marked mass was
medication
effect. limited
12);
axial
nique
able.
Systems,
[30%])
included
sections.
underwent
technique,
contiguous
Several
immediate
but
were
a
receiving
10-mm-
earlier
studies
)
11
=
scanning
a
tech-
of satisfactory
quality
for
MR imaging was performed (Signa; GE Medical The initial imaging sequence
with a 1.5Systems). included
T imager
Ti-weighted 1.0-mm skip, msec/echo
time
coronal, images
skip, 2,000/35-70). administration
dimeglumine Wayne,
images 600/20
(5.0 mm [repetition
msec])
followed
by
if indicated) long-rep(5.0 mm thick, 2.5After the of 0.1 mmol/kg
NJ),
intravegad-
(Magnevist; Ti-weighted
Bercoronal, was
to 6-8 mm to afford full brain All sequences employed a 256 x 192 matrix and one signal averaged. Lesions were characterized as to location, number, and size, as well as CT at-
le-
and
MR white
pattern
signal matter,
intensity and the
relative presence
to
of enhancement.
rate and enhancea valid
21 were hoand three
At the
Number
and
time
of presentation,
many less
than
contrast
(n
lesions
21
diameat least one larger the greatest cm, and in one3 cm. group, the 1 cm
in
material-enhanced
CT scan demonstrated sions in 17 (61%) and
multiple lesolitary lesions in 1 1 (39%). Five of the 1 1 patients with solitary lesions had undergone single-dose contrast enhancement at outside institutions. The number of lesions per patient ranged from 1 to 12 (mean, 3.3). The greatest number of lesions (n = 47 [52%J) were less than 1 cm in size. Thirty-three lesions (36%) were 1-3 cm in diameter, and 1 1 (12%) were greater than 3 cm in diameter. At least one lesion 1-3 cm in diameter was present in 64% of patients, and 36% of patients had at least one lesion greater than 3 cm in greatest diameter.
Contrast-enhanced CT was performed in 15 of the 16 lymphoma patients. Sixteen (76%) of 21 small ( 1 cm
double-dose
sagittal thick,
treatdiag-
obtained
as a moderate size, medical
medical
underwent presumptive
proved with 4), or clinical response (n
Lesion
pa-
serum ancillary
in this
therapeutic
low-up sion
(n
All
examination.
the
toxoplasmosis
12), autopsy
24
(%)
pattern < 1 cm
Milwaukee).
this
India ink fluid, anti-
and
fulfilled
had
of cerebrospinal
were
patients
(b) imaging
negative of other
who or
viewed. (a)
also
9800
single-dose
dexametha-
cytologic
ords ment
na: (n
had
studies
(36) 11(12)
of toxoplasmosis patients (n performed at outside institutions
to
clinical improvement improvement.
A host culture
and
14 pawas in-
directly
and fungi, of cerebrospinal
imaging
47(52)
38 (53) 12(17)
CT was performed
Toxolack of re-
14 patients
with
10)
titers. included
body
went
treatment
21(30)
1-3 cm >3cm Enhancement Lesions
Excluding
or GE
in
at least history
the
another
Eleven
undergone
in
3.3
of
of appropriate
therapy patient,
and
biopsy).
trial
1-12
39*